[I405V polymorphism of the cholesteryl ester transfer protein gene in young and very old individuals]
Related Experiment Video
Updated: Aug 18, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Tiziano Lucchi1, Beatrice Arosio, Marianna Caloni
1Cattedra di Gerontologia e Geriatria, UO di Geriatria, Ospedale Maggiore Policlinico, IRCCS, Università degli Studi di Milano.
Abstract:
This study was designed to analyze the prevalence of I405V polymorphism in the cholesteryl ester transfer protein (CETP) gene, the blood CETP concentration, the lipoprotein pattern and certain clinical endpoints in two populations, one of young and another of very old individuals. We recruited 100 healthy young adults (median age 31 years) and 100 very old subjects (median age 89 years) and analyzed their DNA for the presence of variants V and I of the CETP gene. Subjects with the V/V genotype had lower serum concentrations of CETP. The frequency of this genotype in the very old was more than double that in the young population. Young adults with the V/V genotype had a less atherogenic lipoprotein pattern [lower total and LDL cholesterol levels, lower apolipoprotein (Apo) B levels, and a lower Apo B/Apo A-I ratio] than those with the I/V or I/I genotypes. The very old subjects, particularly those with the V/V genotype, had larger LDL than the young adults. The prevalence of clinical endpoints was much lower among the very old subjects with the V/V genotype.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
Cholinesterases: Distribution and Function
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

